arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

ImmuCell Corporation

ICCC Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$10.44
▼ -0.1% Today
as of Oct 22, 16:49 ET
Last 30 days +7.52% Sep 14 → Oct 22
$9.48 $9.83 $10.18 $10.54 $10.89 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$10.44
High
$10.44
Low
$10.26
Volume
$5,772
Avg Vol
$23,544
Mkt Cap
$87M
P/E (TTM)
27.56
Beta
—
52w High
$12.10
52w Low
$4.52
Div Yield
—
Shares Out
$9M

Recent Press Releases & News last 60 days · 4 items

▸ Show all 4 press releases & news Free account →

ICCC earnings at a glance

Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±1.2% on average; after the most recent report on May 14, 2026 it moved -1.2%. The share price of $10.44 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$4.52
$12
78% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-1.2%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.20$-0.10$0.01$0.11$0.21 Actual $-0.18Actual $-0.12Actual $-0.06Actual $-0.20Actual $-0.09Actual $0.16Actual $0.06Actual $-0.02Actual $0.21Actual $0.20 JunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-701,690$2M$5M$8M$11M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.20 — — — — financials
Thu May 14, 2026Mar/2026 $0.21 — — +31.2% -1.2% earnings
Thu Nov 13, 2025Sep/2025 $-0.02 — — — — earnings
Thu Aug 14, 2025Jun/2025 $0.06 — — — — earnings
Wed May 14, 2025Mar/2025 $0.16 — — — -1.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.09 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.20 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.06 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.12 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.18 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$7M$10M—$6M$6M$8M—$6M
Cost of revenue$5M$6M—$3M$4M$5M—$4M
Gross profit$2M$5M—$2M$3M$3M—$2M
Operating income$2M$2M—$20,075$569,562$1M—$-574,894
Net income$2M$2M—$-139,748$501,880$1M—$-701,690
EPS (diluted)$0.20$0.21—$-0.02$0.06$0.16—$-0.09

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$9M$7M$4M$4M——$4M—
Inventory$9M$9M$9M$10M$8M$7M$7M$7M
Total current assets$21M$19M$17M$17M$17M$16M$15M$14M
Total assets$47M$44M$43M$46M$43M$46M$45M$44M
Long-term debt$7M$7M$7M$8M$8M$10M$9M—
Total liabilities$15M$15M$15M$16M$17M$17M$18M$18M
Total equity$31M$29M$27M$30M$30M$29M$28M$26M

Implied volatility — last 90 days

No IV snapshots yet for ICCC.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

ICCC earnings FAQ

How does ICCC stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.2%, up 0 times and down 2 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.